Savannah Therapeutics
Riverdale, US · Founded 2026
Founders & leadership
TW
Thomas WollanExecutive
Board
MD
Matthew DowlingBoard director
Reported raises · per SEC filings
Form D private placements$3.9M disclosed across 1 round · 2026
▶$3.9MraisedSep 2026 · 28 investors · Other Health CareRule 506(b)
▶$3.9MraisedSep 2026 · 28 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Thomas WollanExecutive Officer
- Matthew DowlingDirector
- Offering amount
- $6M
- Amount sold
- $3.9M
- Minimum investment
- $25K
- Proceeds to insiders
- $576.5K
- First sale
- Apr 2026
- Incorporated
- Corporation, Delaware, 2026
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Savannah Therapeutics raised?
- Savannah Therapeutics has disclosed $3.9M raised across 1 round.
- Where is Savannah Therapeutics headquartered?
- Savannah Therapeutics is headquartered in Riverdale, US.